PGEN Precigen, Inc.
$6.05▲ +0.17%
Healthcare
Other
Volume 596.1K
Avg Volume (10D) 4.55M
Key Metrics & Fundamentals
Market Cap
$2.17B
P/E Ratio
–
Div Yield
0.00%
52W Range
3.04 - 8.98
% vs 50 MA
-16.80%
% vs 200 MA
15.55%
RSI-14
33.0
MACD Histogram
-0.1800
Beta (1Y vs SPY)
1.40
Free Cash Flow
-$18.20M
Gross Rev
$54.98M
Gross Profit
$52.17M
EBITDA
$24.13M
COGS
$2.81M
Operating Exp
$29.53M
Operating Income
$22.64M
EBIT
$22.64M
Pretax Income
$20.07M
Net Income
$20.07M
EPS (Diluted)
0.05
Price & Volume History
Loading chart…
Recent News
Precigen (PGEN) Stock May Be Fully Priced On Its Huge 3 Year Run
Simply Wall St. · Oct 19, 2026 10:13 PM ET
Precigen (PGEN): Commercial Launch Success Validates Early Capital Raise Thesis
Insider Monkey · Oct 12, 2026 11:38 AM ET
Novartis Strengthens RNA Therapeutics Pipeline With $7.8B Abogen Deal
Zacks · Oct 5, 2026 11:21 AM ET
Ultragenyx's Gene Therapy for Sanfilippo Syndrome Wins EMA Validation
Zacks · Oct 5, 2026 10:46 AM ET
PGEN Stock Up More Than 50% in 3 Months: Here's What You Should Know
Zacks · Oct 5, 2026 10:44 AM ET
Novo's Denecimig BLA Review Delayed by FDA Facility Remediation Work
Zacks · Oct 5, 2026 10:36 AM ET
The Zacks Analyst Blog Highlights Abbott, Corcept, Precigen and Bausch Health Companies
Zacks · Oct 5, 2026 8:29 AM ET
Beat the Market Like Zacks: Thermo Fisher, Cricut, Shopify in Focus
Zacks · Oct 5, 2026 7:09 AM ET
4 Low-Beta Healthcare Stocks to Buy Amid Fears of Another Rate Hike
Zacks · Oct 2, 2026 6:57 AM ET
UTHR Prevails in LQDA's Yutrepia Patent Dispute, Stock Up Nearly 13%
Zacks · Oct 1, 2026 11:16 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See PGEN's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.